Jinan Acetate Chemical Co., Ltd. AI Stock Analysis
Jinan Acetate Chemical Co., Ltd. (4763) AI Stock Analysis
Jinan Acetate Chemical Co., Ltd.
(TWSE:4763)
Jinan Acetate Chemical scores well on the strength of its financial profile: outstanding margins, zero debt, a 91% equity-funded balance sheet and 30% return on equity make it one of the financially sturdiest names in the chemicals sector. Valuation adds support, with a 10.1x P/E and a 7.2% dividend yield backed by positive free cash flow. The score is held back by a clear cyclical turn — revenue, earnings and operating cash flow all declined from 2024's record levels, with cash conversion falling below net income — and by weak technicals, as the stock trades under all major moving averages with negative MACD momentum, though oversold RSI and Stochastic readings hint at potential stabilization. Earnings call and corporate event data were unavailable and excluded, with their weight redistributed across the remaining components.
Jinan Acetate Chemical Co., Ltd. (4763) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 42.83B
- Dividend Yield
- 7.00%
- Average Volume (3M)
- 6.86M
- Price to Earnings (P/E)
- 10.5
- Beta (1Y)
- 0.39
- Revenue Growth
- -36.33%
- EPS Growth
- -49.76%
- Country
- TW
- Employees
- 511
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Jinan Acetate Chemical Co., Ltd. Business Overview & Revenue Model
Company Description
Jinan Acetate Chemical Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of cellulose acetate, acetate tows, acetic anhydride, diacetate fiber filament, diacetate fiber tow, and other related pro...
Jinan Acetate Chemical Co., Ltd. Financial Statement Overview
Summary
Exceptional profitability and an essentially risk-free balance sheet, offset by a clear cyclical downturn. Gross margin of 58.6% and net margin of 45.7% remain far above chemical-industry norms, and the company is debt-free with equity funding 91% of assets and a 30.4% return on equity (balance sheet score 93). However, revenue fell to NT$13.2 billion from a record NT$15.7 billion and net income dropped about 27% to NT$6.0 billion (income statement score 79). Cash flow is the softest area (score 71): operating cash flow halved to NT$3.7 billion and covered only ~61% of net income, pointing to weaker earnings conversion, though free cash flow stayed solidly positive at NT$3.2 billion.
Income Statement
79PositiveBalance Sheet
93Very PositiveCash Flow
71Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.77B | 13.23B | 15.71B | 11.03B | 4.27B | 2.71B |
| Gross Profit | 5.75B | 7.75B | 9.94B | 6.89B | 1.68B | 815.09M |
| EBITDA | 5.47B | 7.72B | 10.38B | 6.43B | 1.63B | 535.08M |
| Net Income | 4.13B | 6.05B | 8.34B | 5.18B | 1.25B | 357.50M |
Balance Sheet | ||||||
| Total Assets | 24.23B | 21.84B | 20.98B | 12.00B | 5.41B | 3.64B |
| Cash, Cash Equivalents and Short-Term Investments | 15.42B | 12.98B | 14.40B | 8.57B | 2.01B | 816.17M |
| Total Debt | 399.00K | 0 | 0 | 0 | 507.35M | 1.45B |
| Total Liabilities | 4.50B | 1.77B | 4.58B | 1.68B | 1.76B | 2.00B |
| Stockholders Equity | 19.55B | 19.90B | 16.22B | 10.20B | 3.51B | 1.52B |
Cash Flow | ||||||
| Free Cash Flow | 2.12B | 3.20B | 5.50B | 5.80B | 958.81M | -73.74M |
| Operating Cash Flow | 2.54B | 3.70B | 7.79B | 6.25B | 1.61B | 455.15M |
| Investing Cash Flow | -4.51B | -3.87B | -2.42B | -684.81M | -240.34M | -690.17M |
| Financing Cash Flow | -2.54B | -4.67B | -531.80M | 733.26M | -46.92M | 60.90M |
Jinan Acetate Chemical Co., Ltd. Peers Comparison
Overall Rating
TW:476373Outperform
TW:476672Outperform
TW:177370Outperform
TW:477268Neutral
TW:140957Neutral
TW:131432Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | TWD 42.98B | 10.47 | ― | 7.00% | -36.33% | -49.76% | |
| 72Outperform | TWD 41.72B | 14.59 | ― | 5.29% | 2.93% | 9.20% | |
| 70Outperform | TWD 44.70B | 17.46 | ― | 2.66% | 19.58% | 31.55% | |
| 68Neutral | TWD 32.12B | 37.98 | ― | 1.38% | 163.69% | 66.91% | |
| 57Neutral | TWD 36.07B | 10.43 | ― | 3.94% | -7.23% | 195.60% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 32Underperform | TWD 28.88B | -9.58 | ― | ― | -34.68% | -40.38% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4763 | Jinan Acetate Chemical Co., Ltd. | 43.55 | -8.99 | -17.11% | |
| TW:1314 | China Petrochemical Development Corporation | 7.56 | -1.32 | -14.86% | |
| TW:1409 | Shinkong Synthetic Fibers Corporation | 22.85 | 8.11 | 54.97% | |
| TW:1773 | Shiny Chemical Industrial Co., Ltd. | 150.50 | 10.72 | 7.67% | |
| TW:4766 | Nan Pao Resins Chemical Co. Ltd. | 340.00 | 13.12 | 4.01% | |
| TW:4772 | Taiwan Speciality Chemicals Corporation | 218.00 | -77.33 | -26.19% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
